BRAF Inhibition in Congenital Nevi and Neural Melanosis
JAMA Dermatology · 01.08.2026 · 162 (8) · 859
DOI: 10.1001/jamadermatol.2026.1629 ↗Kurz gefasst
Fachartikel in der Zeitschrift JAMA Dermatology, erschienen am 01.08.2026. Verfasst von Brent J Doolan und 4 weiteren Autor:innen. Beteiligte Einrichtung: Division of Dermatology, The Hospital for Sick Children, Toronto, Ontario, Canada. Die Arbeit nennt 6 Literaturangaben.
Abstract (Originalsprache)
This case report describes sustained neurologic and cutaneous improvement following BRAF inhibition in a patient with BRAF V600E–variant neurocutaneous melanosis.
Autor:innen und Institutionen
- Division of Dermatology, The Hospital for Sick Children, Toronto, Ontario, Canada.
- Division of Haematology/Oncology, The Hospital for Sick Children, Toronto, Ontario, Canada.
- Developmental, Stem Cell and Cancer Biology Programme, Labatt Brain Tumour Research Centre, Hospital for Sick Children, Toronto, Ontario, Canada.
- Department of Medical Biophysics, University of Toronto, Toronto, Ontario, Canada.
Zitieren
APA
Doolan, B. J., Levy, R., McKeown, T., Das, A., & Ramaswamy, V. (2026). BRAF Inhibition in Congenital Nevi and Neural Melanosis. JAMA Dermatology, 162(8), 859. https://doi.org/10.1001/jamadermatol.2026.1629
Vancouver
Doolan BJ, Levy R, McKeown T, Das A, Ramaswamy V. BRAF Inhibition in Congenital Nevi and Neural Melanosis. JAMA Dermatology. 2026;162(8):859. doi:10.1001/jamadermatol.2026.1629
BibTeX
@article{Doolan2026,
author = {Doolan, Brent J and Levy, Rebecca and McKeown, Tara and Das, Anirban and Ramaswamy, Vijay},
title = {BRAF Inhibition in Congenital Nevi and Neural Melanosis},
journal = {JAMA Dermatology},
year = {2026},
volume = {162},
number = {8},
pages = {859},
doi = {10.1001/jamadermatol.2026.1629}
}
EUVIMED